186 related articles for article (PubMed ID: 9712786)
21. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.
Banerjee S; Medina-Fatimi A; Nichols R; Tendler D; Michetti M; Simon J; Kelly CP; Monath TP; Michetti P
Gut; 2002 Nov; 51(5):634-40. PubMed ID: 12377799
[TBL] [Abstract][Full Text] [Related]
22. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
23. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria.
Ermak TH; Ding R; Ekstein B; Hill J; Myers GA; Lee CK; Pappo J; Kleanthous HK; Monath TP
Gastroenterology; 1997 Oct; 113(4):1118-28. PubMed ID: 9322506
[TBL] [Abstract][Full Text] [Related]
24. Systemic immunization with urease protects mice against Helicobacter pylori infection.
Guy B; Hessler C; Fourage S; Haensler J; Vialon-Lafay E; Rokbi B; Millet MJ
Vaccine; 1998 May; 16(8):850-6. PubMed ID: 9627943
[TBL] [Abstract][Full Text] [Related]
25. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
[TBL] [Abstract][Full Text] [Related]
26. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
27. [Immunization with catalase and UreB two-valence vaccine for preventing Helicobacter pylori infection in mice].
Lin HJ; Yang Q; Li J; Liu Y; Wang QY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):436-7. PubMed ID: 18359706
[TBL] [Abstract][Full Text] [Related]
28. B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals.
Losonsky GA; Kotloff KL; Walker RI
Vaccine; 2003 Jan; 21(5-6):562-5. PubMed ID: 12531656
[TBL] [Abstract][Full Text] [Related]
29. The design of vaccines against Helicobacter pylori and their development.
Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic vaccination against Helicobacter pylori infection with attenuated recombinant Salmonella typhimurium urease B subunit and catalase in mice.
Li GQ; Chen MH; Zhu SL; Chen J; Jiao ZY; Chen W; Hu PJ
Chin J Dig Dis; 2004; 5(2):72-5. PubMed ID: 15612661
[TBL] [Abstract][Full Text] [Related]
31. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
[TBL] [Abstract][Full Text] [Related]
32. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.
Corthésy-Theulaz IE; Hopkins S; Bachmann D; Saldinger PF; Porta N; Haas R; Zheng-Xin Y; Meyer T; Bouzourène H; Blum AL; Kraehenbuhl JP
Infect Immun; 1998 Feb; 66(2):581-6. PubMed ID: 9453612
[TBL] [Abstract][Full Text] [Related]
33. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
[TBL] [Abstract][Full Text] [Related]
34. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.
Aebischer T; Bumann D; Epple HJ; Metzger W; Schneider T; Cherepnev G; Walduck AK; Kunkel D; Moos V; Loddenkemper C; Jiadze I; Panasyuk M; Stolte M; Graham DY; Zeitz M; Meyer TF
Gut; 2008 Aug; 57(8):1065-72. PubMed ID: 18417532
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Protection Against
Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
Front Immunol; 2019; 10():1185. PubMed ID: 31191547
[TBL] [Abstract][Full Text] [Related]
36. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
Liu X; Hu J; Zhang X; Fan D
Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
[TBL] [Abstract][Full Text] [Related]
37. Vaccine against Helicobacter pylori: fact or fiction?
Michetti P
Gut; 1997 Dec; 41(6):728-30. PubMed ID: 9462202
[No Abstract] [Full Text] [Related]
38. Inflammation, Immunity, and Vaccine Development for the Gastric Pathogen Helicobacter pylori.
Ikuse T; Blanchard TG; Czinn SJ
Curr Top Microbiol Immunol; 2019; 421():1-19. PubMed ID: 31123883
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate.
Stadtländer CT; Gangemi JD; Khanolkar SS; Kitsos CM; Farris HE; Fulton LK; Hill JE; Huntington FK; Lee CK; Monath TP
Dig Dis Sci; 1996 Sep; 41(9):1853-62. PubMed ID: 8794806
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
